Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter

[1]  A. Sharrocks,et al.  The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.

[2]  T. Graf,et al.  Regulation of eosinophil‐specific gene expression by a C/EBP–Ets complex and GATA‐1 , 1998, The EMBO journal.

[3]  Y. De Launoit,et al.  Requirement of a GT Box (Sp1 Site) and Two Ets Binding Sites for Vascular Endothelial Cadherin Gene Transcription* , 1998, The Journal of Biological Chemistry.

[4]  Cynthia Wolberger,et al.  The Structure of GABPα/β: An ETS Domain- Ankyrin Repeat Heterodimer Bound to DNA , 1998 .

[5]  B. Graves,et al.  Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.

[6]  I. Yada,et al.  Expression and degeneration of tenascin-C in human lung cancers. , 1998, British Journal of Cancer.

[7]  E. Mackie.  Molecules in focus: tenascin-C. , 1997, The international journal of biochemistry & cell biology.

[8]  T. Sakakura,et al.  Expression of fibronectin and tenascin‐C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas , 1997, International journal of cancer.

[9]  H. Ihn,et al.  Sp3 is a transcriptional activator of the human α2(I) collagen gene , 1997 .

[10]  T. Sakakura,et al.  Co‐expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast , 1997, The Journal of pathology.

[11]  M. Meisterernst,et al.  A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter , 1997, Molecular and cellular biology.

[12]  J. Westermarck,et al.  Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors , 1997, Oncogene.

[13]  P. Vernier,et al.  The c-Jun-induced transformation process involves complex regulation of tenascin-C expression , 1997, Molecular and cellular biology.

[14]  F. Viti,et al.  The human homeodomain protein OTX2 binds to the human tenascin-C promoter and trans-represses its activity in transfected cells. , 1997, DNA and cell biology.

[15]  G. Edelman,et al.  Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Ghysdael,et al.  The ETS Family of Transcriptional Regulators , 1997 .

[17]  M. Yaniv,et al.  Oncogenes as Transcriptional Regulators , 1997, Progress in Gene Expression.

[18]  S. Hoffman,et al.  IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. , 1996, The Journal of investigative dermatology.

[19]  R. Tjian,et al.  TAFs mediate transcriptional activation and promoter selectivity. , 1996, Trends in biochemical sciences.

[20]  K. Crossin,et al.  Tenascin: A multifunctional extracellular matrix protein with a restricted distribution in development and disease , 1996, Journal of cellular biochemistry.

[21]  B. Vandenbunder,et al.  The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. , 1996, Experimental cell research.

[22]  Z. Werb,et al.  Synergistic Transcriptional Activation of the Tissue Inhibitor of Metalloproteinases-1 Promoter via Functional Interaction of AP-1 and Ets-1 Transcription Factors (*) , 1996, The Journal of Biological Chemistry.

[23]  N. Bhat,et al.  Generation and characterization of monoclonal antibodies against the ERGB/FLI-1 transcription factor. , 1995, Hybridoma.

[24]  A. Bernstein,et al.  An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. , 1995, Molecular and cellular biology.

[25]  S. Schenk,et al.  The complexity in regulating the expression of tenascins , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  L. Zardi,et al.  The first untranslated exon of the human tenascin‐C gene plays a regulatory role in gene transcription , 1995, FEBS letters.

[27]  M. Kusakabe,et al.  Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis? , 1995, Cancer letters.

[28]  G. Edelman,et al.  Structural and functional similarities between the promoters for mouse tenascin and chicken cytotactin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Trojanowska,et al.  Characterization of a GC-rich Region Containing Sp1 Binding Site(s) as a Constitutive Responsive Element of the α2(I) Collagen Gene in Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[30]  R. Gherzi,et al.  Human Tenascin Gene , 1995, The Journal of Biological Chemistry.

[31]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[32]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[33]  H. Kawakatsu,et al.  Specific expression of tenascin in human colonic neoplasms. , 1993, British Journal of Cancer.

[34]  J. Ghysdael,et al.  Synergistic activation of the HTLV1 LTR Ets‐responsive region by transcription factors Ets1 and Sp1. , 1993, The EMBO journal.

[35]  E. Wisse,et al.  Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. , 2008, Liver.

[36]  J. Heath,et al.  Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. , 1992, Biochimica et biophysica acta.

[37]  J. Testa,et al.  The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  G. Edelman,et al.  Activation of the cytotactin promoter by the homeobox-containing gene Evx-1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Tjian,et al.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. , 1991, Genes & development.

[40]  S. McKnight,et al.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. , 1991, Science.

[41]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[42]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[43]  E. Hay,et al.  Cell Biology of Extracellular Matrix , 1988, Springer US.

[44]  Z. Werb,et al.  Extracellular Matrix Degradation , 1991 .

[45]  N. Bhat,et al.  Monoclonal antibodies specific to human ETS-2 oncoprotein: recognition of epitopes clustered on the B domain. , 1990, Hybridoma.

[46]  G. Edelman,et al.  Identification and characterization of the promoter for the cytotactin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Wasylyk,et al.  The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.

[48]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.

[49]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[50]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.